Sarah Schick is an associate on DLA Piper's Food and Drug Administration team. She focuses her practice on regulatory matters impacting the life sciences and healthcare industries.

Sarah's practice centers on providing clients with strategic counsel on regulatory matters intersecting with litigation or corporate decision making. She has experience advising on clinical trial issues, contractual matters, compliance programming and risk management.

Prior to joining DLA Piper, Sarah served as in-house counsel for a publicly traded biopharmaceutical company and also gained experience working in the legal department for a large hospital system in Texas. Prior to her legal career, she was involved in clinical trial project management, health outcomes research and healthcare diplomacy.